Nephrology

  • Extraosseous calcification in kidney disease
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 223;

    The following article in the February 2022 issue contained an error: Bartolomeo K, Tan XY, Fatica R. Extraosseous calcification in kidney disease. Cleve Clin J Med 2022; 89(2):81–90. doi:10.3949/ccjm.89a.21073

  • Extraosseous calcification in kidney disease
    Extraosseous calcification in kidney disease
    Korey Bartolomeo, DO, Xin Yee Tan, MD and Richard Fatica, MD
    Cleveland Clinic Journal of Medicine February 2022, 89 (2) 81-90; DOI: https://doi.org/10.3949/ccjm.89a.21073

    A review of the pathogenesis, presentation, diagnosis, and treatment of vascular and soft tissue calcifi cation.

  • SGLT-2 inhibitors are potential game-changers (for more than diabetes)
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine November 2021, 88 (11) 588-589; DOI: https://doi.org/10.3949/ccjm.88b.11021

    Data from large clinical trials and improved understanding of the biologic effects of these drugs are changing expectations for the clinical course in patients with diabetes, as well as chronic kidney disease and heart failure.

  • SGLT-2 inhibitors in heart failure: Time for broader eligibility and earlier initiation
    Enrico G. Ferro, MD, Bertram Pitt, MD and Deepak L. Bhatt, MD, MPH
    Cleveland Clinic Journal of Medicine November 2021, 88 (11) 601-606; DOI: https://doi.org/10.3949/ccjm.88a.21045

    SGLT-2 inhibitors remain vastly underused in clinical practice despite their broad cardiorenal benefits.

  • Can I place a peripherally inserted central catheter in my patient with chronic kidney disease?
    Nora Hilda Hernandez Garcilazo, MD, Mohamed Hassanein, MD, Tushar J. Vachharajani, MD and Evamaria Anvari, MD
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 431-433; DOI: https://doi.org/10.3949/ccjm.88a.20173

    Future need for permanent dialysis access is an important consideration.

  • How do you effectively evaluate the elderly for alcohol use disorder?
    Moronkeji Fagbemi, MD, FASAM
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 434-439; DOI: https://doi.org/10.3949/ccjm.88a.20123

    A brief review of clues to an underrecognized and underdiagnosed problem with physical as well as emotional and social consequences.

  • The obesity paradox in heart failure: What is the role of cardiorespiratory fitness?
    Asad Khan, MD, Erik H. Van Iterson, PhD and Luke J. Laffin, MD
    Cleveland Clinic Journal of Medicine August 2021, 88 (8) 449-458; DOI: https://doi.org/10.3949/ccjm.88a.20098

    What should these patients be advised about weight management and about cardiorespiratory fitness, a major factor influencing the paradox?

  • Tuberous sclerosis complex
    Jesica Martín Carmona, MD, Elisabeth Gómez Moyano, MD, PhD, Ana Raquel de Castro Almeida, MD and Leandro Martínez Pilar, MD, PhD
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 367-368; DOI: https://doi.org/10.3949/ccjm.88a.20075

    A rare disorder caused by mutations of tumor-suppressor genes.

  • Promoting physical activity in older women to maximize health
    Augustine Chavez, MD, Robert Scales, PhD and Juliana M. Kling, MD, MPH
    Cleveland Clinic Journal of Medicine July 2021, 88 (7) 405-415; DOI: https://doi.org/10.3949/ccjm.88a.20170

    The optimal type, intensity, and level required to achieve specific health outcomes depend on the disease the patient and clinician are trying to prevent or manage.

  • Medical complications of bulimia nervosa
    Allison Nitsch, MD, Heather Dlugosz, MD, Dennis Gibson, MD and Philip S. Mehler, MD, FACP, FAED
    Cleveland Clinic Journal of Medicine June 2021, 88 (6) 333-343; DOI: https://doi.org/10.3949/ccjm.88a.20168

    Complications can affect all body systems, but especially the renal and electrolyte systems.

Pages